on October 23, 2003
Published online before print October 23, 2003, doi: 10.1161/01.STR.0000094421.61917.71
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on June 12, 2003
From the Department of Neurology (K.W., H.S., P.G.B., S.P.F.) and Stroke and Neurovascular Regulation Laboratory (K.W., M.A.M.), Massachusetts General Hospital, Harvard Medical School, Boston; and ViaCell Neuroscience, ViaCell, Inc, Worcester, Mass (S.P.F.). * To whom correspondence should be addressed. E-mail: Sfinklestein{at}viacellinc.com.
Background and Purpose--Intracisternal basic fibroblast growth factor (bFGF) enhances sensorimotor recovery after focal cerebral infarction in rats. One possible mechanism is stimulation of endogenous progenitor cells in brain. We investigated the effects of intracisternal bFGF on brain progenitor cells after stroke. Methods--Proliferating brain cells were labeled with bromodeoxyuridine (BrdU) before middle cerebral artery (MCA) occlusion or sham surgery in rats. bFGF (0.5 µg) or vehicle was administered intracisternally at 24 and 48 hours after MCA occlusion, and rats were killed at 7, 14, or 21 days after stroke. Immunohistochemistry for BrdU and neuron- or astrocyte-specific markers was used to characterize progenitor cells and their progeny in the subventricular zone and dentate gyrus of the hippocampus. Results--Infarct size did not differ among rats with or without bFGF treatment. MCA occlusion alone increased the number of BrdU-labeled cells in the ipsilateral subventricular zone at days 7 to 21, and there was a trend toward increased cell proliferation with bFGF treatment. In the dentate gyrus, the number of BrdU-labeled cells was increased bilaterally after MCA occlusion (peak at day 7). This increase was greater after bFGF treatment. In the subventricular zone, 30% of BrdU-labeled cells were immunopositive for the immature neuron-specific marker doublecortin at day 7, and their number declined to 2% at day 21. In the dentate gyrus, the majority of BrdU-labeled cells colabeled with doublecortin at day 7, becoming NeuN positive at day 21. Conclusions--Stroke produces significant changes in progenitor cells in brain that are augmented by bFGF treatment.
Accepted on July 8, 2003
Effect of Basic Fibroblast Growth Factor Treatment on Brain Progenitor Cells After Permanent Focal Ischemia in Rats
Kuniyasu Wada MD;
Key words: cerebral ischemia • dentate gyrus • fibroblast growth factor 2 • progenitor cells
This article has been cited by other articles:
 |
|
 |
|
  S. C. Cramer, W. J. Koroshetz, and S. P. Finklestein The Case for Modality-Specific Outcome Measures in Clinical Trials of Stroke Recovery-Promoting Agents Stroke, April 1, 2007; 38(4): 1393 - 1395. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Ikeda, N. Nonoguchi, M. Z. Zhao, T. Watanabe, Y. Kajimoto, D. Furutama, F. Kimura, M. Dezawa, R. S. Coffin, Y. Otsuki, et al. Bone Marrow Stromal Cells That Enhanced Fibroblast Growth Factor-2 Secretion by Herpes Simplex Virus Vector Improve Neurological Outcome After Transient Focal Cerebral Ischemia in Rats Stroke, December 1, 2005; 36(12): 2725 - 2730. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Evans, P. V. Choudary, C. R. Neal, J. Z. Li, M. P. Vawter, H. Tomita, J. F. Lopez, R. C. Thompson, F. Meng, J. D. Stead, et al. Dysregulation of the fibroblast growth factor system in major depression PNAS, October 26, 2004; 101(43): 15506 - 15511. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Tanaka, K. Kitagawa, S. Sugiura, E. Matsuoka-Omura, T. Sasaki, Y. Yagita, and M. Hori Infiltrating Macrophages as In Vivo Targets for Intravenous Gene Delivery in Cerebral Infarction Stroke, August 1, 2004; 35(8): 1968 - 1973. [Abstract] [Full Text] [PDF]
|
|